Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Tumor neoantigen-specific T cells
Email alerts
Tumor neoantigen-specific T cells
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
Michael
Fehlings
,
Suchit
Jhunjhunwala
,
Marcin
Kowanetz
,
William E.
O’Gorman
,
Priti S.
Hegde
,
Hermi
Sumatoh
,
Boon Heng
Lee
,
Alessandra
Nardin
,
Etienne
Becht
,
Susan
Flynn
,
Marcus
Ballinger
,
Evan W.
Newell
,
Mahesh
Yadav
Journal for ImmunoTherapy of Cancer
Dec 2019,
7
(1)
249;
DOI:
10.1186/s40425-019-0695-9
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(531)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(930)
Commentary/Editorials
(139)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(53)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(208)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(401)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(142)
Reviews
(238)
Open access
(4833)
Press releases